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AN association between anaemia and malignancy is a common finding in
man (Sturgis, 1955) and has also been recorded in experimental animals (Price
and Greenfield, 1958). In many instances, however, the exact causal relation-
ship between the two conditions is not clear. The available hypotheses, both in
general and particular, have been reviewed by Price and Greenfield (1958) and
by Simpson (1961). The work of Belcher and Simpson (1960) and of Simpson
(1961) is most relevant to the present study. These authors (following pre-
liminary reports by Belcher, 1958, 1959) described red-cell destruction with
consequent anaemiain " August " strainratsbearing the transplantable mammary
adenocarcinoma, R 2426. It was suggested that the agent responsible, which was
separable from the tumour, could be a virus. An investigation ofa similar agent
(NKLA), associated with the NK/Ly ascites, has been made and will be reported
here.
MATERIALS AND METHODS
Mice.-Two to 4 month-old mice of either sex of the CBA strain were used
principally. The CBA strain has been maintained by inbreeding in the Chester
Beatty Research Institute for many generations and can be considered genetically
homogeneous. Other inbred Chester Beatty mouse strains used were the BALB/c,
C57BL and A, and colony-bred stock mice. Colony-bred C3 and Swiss mice
were used for that part of the work carried out in the Oncopathology Institute,
Budapest. The rats used were of the Chester Beatty colony-bred Wistar albino
strain.
Tumours
(i) NK/Ly ascites tumour (N6meth and Keilner, 1960).-The tumour was
maintained as ascites in the peritoneal cavity of CBA mice, being passaged
about every 10th day. When required for experiment tumour cells were taken
1 week after passage.
(ii) Other tumours.-The following transplanted ascites tumours were used:
Sa-l, C+ leukaemia, EL4, BP8, Krebs, S37 and Ehrlich (hyperdiploid) growing
in the A, BALB/c, C57BL, CBA, C57BL, Stock and BALB/c strains of mice
respectively. The last three of these tumours have no notable strain specificities,
the remainder may be regarded as strain specific.
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Methods
(i) Haematological.-Mice were bled from the tail. Estimated components
of the blood were haemoglobin (Hb), packed cell volumes (PCV), reticulocytes,
platelets, total white blood cells, mononuclear- andpolymorphonuclear leucocytes.
Amicro-haematocrit centrifuge wasusedforestimation ofPCV, otherwisestandard
haemocytometric methods were employed.
(ii) Serum and red cells.-Serum was obtained from blood collected after
decapitation. The blood was allowed to stand at 4 C:. for at least 1 hour and was
then spun at 1700 g. for about 10 minutes. The supernatant was collected and,
when necessary, stored at -79° C. in glass ampoules. Serum was injected
intravenously into mice in 01 ml. aliquots. Red cell suspensions were prepared
by diluting whole blood into isotonic citrate: saline (1: 10). Except where
indicated, 0.1 ml. of a 20 per cent red blood cell suspension was injected. No
efforts were made to exclude white cells.
EXPERIMENTS AND THEIR RESULTS
(1) The basic experiment
The suspicion that the NK lymphoma was responsible for, or associated with,
anaemia in tumour-bearing mice arose from experiments in which attempts
were made to arrest the growth of the tumour by means of Degranol (i,6-Di-/1-
chloroethylamino-1,6-dideoxy-mannitol) or irradiation (Lapis and Davies, 1962).
The basic experiment which confirmed this suspicion was performed by injecting
3 x 106 cells of NK/Ly ascites into 20 mice and studying their peripheral blood
after various time intervals. Five mice were bled at a time, but in order to avoid
any effect of bleeding per se, no mouse was bled more frequently than once
every 8 days.
The results are set out in Fig. 1. It can be seen that both the counts ofplate-
lets and white cells were depressed on the 2nd day after injection (P < 0.01)
but thereafter recovered. The haemoglobin and PCVs fell sharply after the 4th
day (P < 0 01) but recovered to normal by the 10th day. Associated with the
low red cell levels was a considerable reticulocytosis (P< 0.01 after the 4th day)
commencing about the 4th day and continuing for at least 21 days.
(2) Anaemia after injection ofserum or red cells
Following Belcher and Simpson (1960) it was decided to determine whether
the agent responsible for the anaemia could be obtained free from the tumour.
Serum and red cells were taken from tumour-bearing CBA mice and injected,
separately, into CBA mice. The PCVs and haemoglobins of the injected mice
were recorded on alternate days until apparently stable values were obtained.
As before, mice were bled in batches. Both serum and washed red cells caused
anaemia and their effects were approximately the same. The recovery to normal
haemoglobin levels lagged behind recovery of the PCVs. This is perhaps to be
expected if rapid red cell proliferation follows the anaemic phase. In an as yet
incomplete series ofexperiments it has proved possible to passage the agent every
7 days by means of injections of 0 1 ml. of serum from infected mice. Up to the
30th passage no loss of infectivity is apparent.
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(3) Tests for antibody
It seemed possible that the anaemia observed was due to antibody produced,
perhaps by the tumour against the host, perhaps by the host itself, this latter
case qualifying as an auto-immune reaction. In either instance it might have
been possible to detect antibody in the serum, or coating the red cells, of anaemnic
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FIG. 1.-The peripheral blood values of CBA mice at various times after their intravenous
injection with 3 x 106 cells of NK/Ly ascites.
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mice. Accordingly, a rabbit anti-mouse-serum antiserum was absorbed with
mouse red cells, and used in both direct and indirect Coomb's tests. All tests
were done at room temperature and at 40 C. All were negative. Neither was
it possible to demonstrate that the serum of anaemic mice had any lytic effect
in vitro upon mouse red cells-various sources of complement having been added
to the reaction mixtures. Serum from anaemic mice was absorbed with normal
washed red cells (1 vol. serum: 1 vol. packed red cells) twice for 1 hour at 40 C.
(.
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This did not abolish the capacity of the serum to produce anaemia upon injection
into CBA mice. Though not exhaustive, these tests did not in any way support
the hypothesis that an antibody reaction was responsible for the anaemia.
(4) Assay of NKLA.
Belcher and Simpson (1960) showed that the apparent amount of agent in
tumour-bearing rats was related to the time after tumour implantation. Thus,
serum from rats which had received the tumour 1 day previously upon injection
into other rats produced no anaemic episode; serum from rats which had received
the tumour 3 days previously, gave a positive reaction within 12 days. Serum
taken 14 days after tumour injection elicited an anaemic episode within 2 days.
The length of time for the anaemic episode to develop might then be an indication
of the amount or activity of the agent present.
An attempt was made to repeat this type of assay. Serum and red cells were
taken from CBA mice 2, 4, 6, 8 and 12 days after intravenous injection of 3 X 106
cells of NK/Ly ascites. The serum and red cells were injected separately into
groups of CBA mice and their haemoglobin and PCVs were determined every
other day for 12 days. As before, bleeding was done on batches of different
mice rather than serially on the same mice. The results are shown in Table I.
TABLE I. The PCVs and Haemoglobin Levels (Hb) of CBA Mice at Various Time
Intervals after an Injection of Red Cells or Serum from CBA Mice which
had at various timespreviously received 3 x 106 Cells ofNK/Ly Ascites
Time in days after injection of serum or red cells
Time in days Serum (S) 2 4 6 8 10 12
after injection or - -
of tumour red cells (C) PCV Hb PCV Hb PCV Hb PCV Hb PCV Hb PCV Hb
2 C 54 105 46 87 30 66 34 60 51 108 43 97
S 54 109 50 97 29 63 34 62 43 93 46 98
4 C 48 107 49 101 41 100 39 76 44 74 50 106
S 49 102 52 100 40 98 44 85 47 81 46 106
6 C 50 95 49 97 34 67 28 56 43 68 46 77
S 54 93 39 81 28 57 32 61 46 83 77
8 C 50 114 38 83 28 53 36 50 42 73 48 83
S 52 120 42 80 30 60 40 64 46 78 46 92
12 C 54 101 45 83 30 61 38 63 35 63 51 92
S 51 106 34 69 33 74 40 62 45 87 51 92
Each value given is a mean from at least three mice. Both sera and red cells
appeared to have a similar effect. All injections seemed to have similar potencies.
As the PCV and haemoglobin values ran roughly together it was decided to
abandon haemoglobin determinations in subsequent investigations. Further,
as in every case the PCV was lowest on the 6th or 8th day, it was decided to sample
on the 6th day and, if the result was negative, again on the 8th day. In addition
reticulocyte determinations were to be made on the 10th day at a time when the
maximum degree of reticulocytosis was apparent. As injection of red cells and of
sera had given similar results, it was decided to concentrate on injections of sera.
On this basis sera were removed and assayed from mice shortly after intravenous
injection of the NK lymphoma (Table II). There was a slight indication from
the reticulocyte counts that the amount of NKLA declined by 15 hours after
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TABLE II.-The Mean PCV and Reticulocyte Counts of CBA Mice injected with
01 rml. of Serum from CBA Mice which had received 3 x 106 Cells of the
NK/Ly Ascites at various times previously
Time in hours after Reticulocytes per cent
injection of tumour PCV on day 6 on day 10
1 . 30 . 16
3 . 28 . 21
6 . 28 21
15 . 32 . 6
24 . 30 . 7
injection of the tumour. It was, however, clear that assay by measuring the
time taken to produce anaemia was not useful. Accordingly, it was decided
to make various dilutions of sera and red cells from mice 6 days after intravenous
injection of NK/Ly ascites, before injection into test mice (Table III).
TABLE III.-The PCV per cent and Reticulocyte per cent Level of CBA Mice at
various times after their Injection with various Dilutions of Serum or Red
Cells from Mice which had 6 days previously received 3 x 106 Cells of
NK/ILy Ascites Intravenously
PCV on day
Serum or , Reticulocytes on day
red cells Dilution 6 8 10
Red cells . 0 . 34 28 Not determined
1:50 . 43 28 8
1:500 . 48 40 . 5
1:5,000 . 49 46 . 2
1:500,000 . 46 48 . 2
Serum 0 25 . 33
1:100 . 23 . 25
1:1,000 . 42 40 14
1:10,000 . 43 47 . 4
1:100,000 . 47 45 . 4
1:1,000,000 . 47 46 . 1
Without doubt more agent was present in the serum than associated with
washed red cells. Further, the method of assay was satisfactory. The dilution
study was extended to encompass a wider range of times. Assay was made of
agent in the serum of mice which had been injected with serum from tumour-
bearing mice. The results are recorded in Table IV; it seemed that the titre
of agent free in the serum dropped slightly upon injection, as might be expected
with an approximately 1 in 20 dilution (the blood volume of a 20 g. mouse is
about 2 ml.). After 15 hours the titre was reduced tenfold and rose 50 fold within
the next 33 hours. Six days after injection the titre was lower than at 48 hours,
but was thereafter maintained until 14 days. A later experiment, of which the
results are shown in Table V, showed clearly that the titre drops sharply within
3 hours of injection and remains low until 12 hours, after which it rises slowly.
Such a growth pattern ofmultiplication might be expected of a virus.
(5) Electron microscopy
Accepting as a working hypothesis that the NKLA was in fact a virus, it
was decided to attempt visualization with the electron microscope. Serum
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TABLE IV.-The PCV's, per cent, and reticUlocytes, per cent, of CBA mice injected
with 0 1 ml. ofserum or diluted serumfrom CBA mice infected at various times
previously (first column) with the NKLA.
Time after injection
ofinfectious serum
I hour
15 hours
48 hours
6 days
14 days
Serum
dilution
0 . 30
1 :100 . 29
1 :500 . 37
1 :1,000 . 34
1:5,000 . 44
1 :10,000 . 48
0 . 32
1 :100 . 34
1 :500 . 48
1 :1,000 . 46
1: 5,000 . 43
1 :10,000 . 45
0 . 29
1 :100 . 30
1:500 . 31
1 :1,000 . 28
1: 5,000 . 26
1 :10,000 . 42
0 . 25
1 :100 23
1 :1,000 . 42
1 :10,000 . 43
1 :100,000 . 47
1:1,000,000 . 47
1 :100 . 36
1:500 . 36
1 :1,000 . 36
1: 5,000 . 42
1:10,000 . 42
Reticul1ocytes
PCV on day percentonday
6 8 10 15
16
- 22
38 . 12
33 . 16
40 . 1
47 . 1
6
35 . 20
51 . 3
45 . 4
47 . 4
44 . 3
6
* 9
_ 18
14
40 . 2
34 . 33
39 25
32 . 14
48 . 4
52 . 4
50 1
40 . 7
38 . 12
39 . 15
42 . 3
43 . 6
10
8
2
2
2
2
3
3
TABLE V.-The Infective Titres, as measured by ability to induce Anaemia, of
Sera of Mice various times after their injection with 01 ml. of Serum
containing the NK Lymphoma Agent
Titre*
>10,000
* <100
100
100
100
< 1,000>100
1,000
100
<5,000>1,000
* Reciprocal of ultimate infective dilution.
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Time in hours
after injection
0
3
6
9
12
15
18
21
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from tumour-bearing and from normal mice was collected and centrifuged at
10.000 g. for 20 minutes to remove large debris. The supernatants were collected
and spun at 100,000 g. for 1 hour. The pellets were sectioned and then examined
in the electron microscope. The pellet from the serum of tumour-bearing mice
contained a number of virus-like particles (Fig. 2); that from normal serum did
not. The observation of virus-like particles has so far been restricted to two
samples of serum from tumour-bearing mice, but it was sufficiently encouraging
to continue with an attempt to characterize the postulated virus.
(6) Heat antd ether sensitivity
Infectious sera were kept for 30 minutes at 370, 560 or 80° C. preceding injection
into test mice. Other sera were treated with ether (1 ml. serum: 0-1 ether)
overnight before test. Table VI gives the test results, i.e. virtually complete
inactivation at 560 C. and with ether.
TABLE VI. The PCVs and Reticulocyte Counts of Mice at various times after
injection ofInfectious Serum whichhad been treated in a variety ofways
PCV on day Reticulceytes
per cent on day
Treatment of serum 6 8 10
37°C. for 30 minutes 22 20
56°C. for 30 minutes 50 45 2
80'C. for 30 minutes 49 60
Ether for 12 hours 47 45 2
(7) Mouse-strain specificity
All experiments had so far been with CBA mice. A number of experiments
were devised to test the specificity of the NKLA. BALB/c and C57B1 mice
were injected intravenously with 3 x 106 cells of the NK/Ly ascites and their
PCVs and haemoglobin values followed daily for 15 days. No marked anaemia
was observed though the C57B1 showed somewhat depressed haemoglobins (70
per cent normal) on the 10th day after injection of tumour. The PCVs of these
mice were not, however, significantly depressed.
Serum was taken from a number ofBALB/c mice some 14 days after implanta-
tioni of tumour, and injected into CBA mice. A slight anaemia resulted. C3
(the strain of origin of the tumour) and a strain of Swiss mice were injected with
tumour and components of the blood were analysed for a number of days. The
results were equivocal; some depression of platelets and red cells was observed
but the effect was by no means as marked as when the NK/Ly is injected into
CBA mice. The inference from all these experiments is either that the agent
is specific in its growth requirements or that C3, BALB/c, C57B1 and Swiss mice
are not so susceptible to attack as CBA. It was thought possible that the agent
was carried but without pathological effect in non-susceptible mice. However,
when serum from normal BALB/c mice was injected into the susceptible CBA
EXPLANATION OF PLATE
FIG. 2.-Electron micrograph of a section of the pellet obtained by spinning serum from mice
6 days after the i.p. injection with 3 x 106 cells of NK/Ly ascites at 100,000 g. for 1 hour.
( x 80,000.)
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mice no anaemia resulted. It thus seemed likely that susceptibility was related
to the degree of (immune) control which could be exercised over the activity of
the agent.
(8) The period ofinfectivity, development of immunity and the effect of suppression
ofthe immune response
Serum taken from CBA mice which had been injected with infectious serum
2 months previously and which had undergone an anaemic phase did not produce
anaemia when injected into further CBA mice. Moreover, CBA mice which had
been infected with serum and which had undergone one anaemic phase were not
apparently affected by further injection of either tumour or infectious serum.
This information supported a picture of susceptibility associated with a slow
immune response which, when it did develop, suppressed the agent and perhaps
eradicated it from the previously infected animal. To test this hypothesis by
artificially suppressing the immune response, groups of 20 BALB/c or CBA mice
were injected with infectious serum and about 30 minutes later given 500 or 600 r
respectively (Table VII). Control mice in groups of 10 were injected with normal
TABLE VII.-The Mortality of CBA and BALB/c Mice Irradiated at various times
after their injection with Serumfrom Mice carrying the NK Lymphoma
Radiation Time of irradiation after Percentage
Mouse strain dose (r) injection of virus mortality Remarks
CBA . . 600 . i hour . 100 All anaemic
CBA . 600 . 28 days . 50
BALB/c . . 500 . i hour . 50
CBA . . 600 . No virus given . 0 . Not markedly anaemic
BALB/c . . 500 . No virus given 0 . Not markedly anaemic
serum before irradiation. Ofthe CBA mice, all those infected died, all the controls
lived. Half the infected BALB/c mice died whereas all the controls survived.
All infected mice showed profound anaemia (PCV < 10 per cent) and had in-
fective sera. Post mortem examination of representative infected CBA mice
revealed almost complete aplasia of the blood forming tissues. A further group
of CBA mice which had been infected some 2 months previously, and had gone
through an anaemic phase, but which did not appear to carry the agent, were
given 600 r. Half of these mice died, all showed profound anaemia.
From these experiments it was tentatively concluded that susceptibility was
determined by the strength of the immune response and further that apparently
agent-free animals, infected some time previously, did in fact still carry the
agent. It is, however, not possible on the present evidence to be absolutely
sure that resistance to the virus is of an immunological nature.
(9) Transplantable tumours other than the NK lymphoma
In order to determine if agents similar to the NKLA were common a number
of other tumours were tested. The method was simply to inject a tumour into
a group of suitable hosts and follow the PCVs and reticulocytes as before. If
anaemia was apparent, serum was taken from the tumour-bearing animals and
injected into further test animals. The results of the survey are given in Table
VIII. It can be seen that anaemia is commonly associated with tumours par-
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ticularly when the mice are in a terminal condition. However, an anaemia-
producing agent similar to the NKLA was detected only in animals carrying
the Krebs ascites. The Sarcoma-I requires further investigation.
TABLE VIII.-The PCVs of various Strains of Mice or Wistar Rats injected with
various Tumours or Sera derivedfrom Tumour-Bearing Animals
Strain of
animal
injected
PCV on day
3 5 6 7 8 1 1A-3 1
3 5 6 7 8 10 13 15
Reticulocytes
on day
8 10 13 16
Ehrlich ascites BALB/c
Serum from Ehrlich bearing
mice
EL4 ascites . . C57BL
Krebs ascites . C57BL
* Serum from Krebs bearing
mice
Serum from test mice* above
S37 ascites . . Stock
Serum from S37 bearing . CBA
stock mice
Walker solid . . Wistar
Serum from Walker bearing .
rats
Sarcoma-I ascites.
rat
Wistar
rat
A
- 31
44
_ -_ _ - 10 -
46 - - 4
- 46 46 38
15
- 28 - - 42
- 36 34
39
- - 38 43
12 2 - -
- - 13-
- 6- 5
7--
5-
- 49 - 32 28
44 41 40 - 40
- 43 37 - 39 43 32 12 20
BP8 ascites . . . CBA
Serum from mice bearing . ,,
BP8
C+ leukaemia ascites . BAL
38 44 49 48 51 10 3
43 43 - 43 - 2
,B/c - 48 50
7
45 -- - 2 - -
It was of particular interest that the S37 tumour did not have any marked
association with an anaemia-producing agent. It is known that this tumour
contains an agent which elevates the serum lactic dehydrogenase (LDH) levels
in tumour-bearing mice and that the agent is separable from the tumour. It has
also been found that the NKLA elevates LDH (Rowson, personal communication).
However, on the evidence presented it seems unlikely that the agents from the
NK/Ly and the S37 are the same entity.
DISCUSSION
It is not yet possible to be certain that the NKLA is a virus. Infectious
serum drawn through a bacteriological filter (pore size 1-1 5 ,u) remained infectious.
Similarly the supernatant of infectious serum which was spun at 100,000 g. for 1
hour retained infectivity. In neither case was a titration made in order to assay
the extent to which infectivity had been lost. Though the omission will be
remedied in future experiments, neither filtration of the type adopted nor centri-
fugation is likely to reveal anything except that the agent is considerably smaller
than a bacterial cell.
The fact that the serological tests for antibody were negative by itself, signi-
fies little. It is however, difficult to see how a serum antibody could multiply
Injection
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as the agent was shown to do. It is particularly significant that the agent can
be passaged without (as yet) gross loss of infectivity.
Itisperhapssurprising thatifthe agentis a virus itshouldaffect all components
of the haematopoietic system but, as at present, so little is known of the manner
in which cell destruction is effected, this lack of host cell specificity may be more
apparent than real.
All in all it seems proper to put forward as a working hypothesis, that the
NKLA is a virus or a group of viruses. Accepting this, comparison can be made
between the NKLA, other infectious anaemias and other tumour viruses.
Probably the best known infectious anaemia is that of horses (EIA) the viral
aetiology of which has recently been investigated by Hasumi (1956). EIA is
known to occur naturally and can also be induced by injection of purified viral
isolates (Hasumi, 1959). In either case its characterization is a matter of great
complexity but the features which are of special interest are the appearance of
siderocytes and, at the same time, a reduction of variable degree in the number
of circulating red cells. Both the appearance of siderocytes and the anaemia
can be transient. The virus causing the anaemia does not appear to be onco-
genic neither is it obviously associated with tumours. Thus in the present
context it simply serves as an example of an infectious anaemia caused by a virus
and to this extent may parallel the NKLA.
Of greater relevance, however, is the work of Sacks and Egdahl (1960) and
Belcher and Simpson (1960). Sacks and Egdahl (1960a and b) described a
" multipotent filterable agent in rats capable of producing acute hemolytic
anaemia." It appears that the agent was first discovered in association with the
Walker 256 and also the Miller hepatoma, which are widely used transplantable
tumours. Rats receiving these tumours developed severe haemolysis, haemo-
globinuria and severe anaemia with haemoglobin levels as low as 1-2 g. per cent.
Further investigation revealed that the anaemia was caused by a replicating
agent which could be separated from either tumour. The anaemia could be
transmitted by a filtrate of serum or lysed erythrocytes from infected animals.
The agent itself was oncogenic being apparently responsible for the induction of
tumours at various sites and at various times after injection. Perhaps the most
interesting finding was that animals which had been infected with FHA (filterable
haemolytic anaemia) and which had undergone an anaemic phase were completely
immune to further infection by the agent and also partly immune to a wide
variety of transplantable tumours. Sacks and Egdahl were careful to point out
that the FHA, being filterable (and for a variety of other reasons) could not
be Bartonella muris (Weinman, 1944); for the same reasons, neither could the
NKLA.
The work of Belcher and Simpson (1960) and Simpson (1961) was rather
similar, showing as it did the presence of a filterable agent in association with a
rat tumour (the R2426 adenocarcinoma). Again the agent was separable from
the tumour and could induce a severe anaemia on injection into rats. That the
anaemia was haemolytic was proved by an elegant series ofexperiments involving
red-cell labelling with Cr5l. As far as could be determined the agent was present
in all organs of infected rats. It was quickly destroyed at 600 C. but was not
sensitive to ether. The agent did not appear to be oncogenic in adult rats.
Neither was there any indication that infection with the agent conferred any
degree of resistance to tumour growth. This point would however require a
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more elaborate investigation to be established with certainty. The agent could
be found free in the serum but was mainly associated with the red cells ofinfected
animals. Lysed red cells from infected animals were far less infective than intact
cells. The D266 mammary adenocarcinoma was also found to have associated
with it a similar agent.
The transmissible agent isolated by Old, Benacerraf, Clarke, Carswell and
Stockert from the Sarcoma 180, which produced anaemia and death in irradiated
mice, as well as many other symptoms in non-irradiated mice, should also be
considered as a further example of an agent similar to the NKLA.
These examples of haemolytic agents associated with tumours are directly
comparable with the NKLA. There remain differences in detail between the
various agents suchaswhether or not they areoncogenic. TheNKLAforinstance
did not induce tumours when injected into newborn CBA mice but it did kill
70 per cent ofthe mice injected, whereas the FHA is definitely oncogenic in adult
rats. It should, however, now be possible, knowing of the existence of the three
agents, to devise experiments to compare them more fully.
Riley and his associates (1960) discovered a filterable, heat-labile agent
associated with some twenty-six different mouse tumours which, with or without
tumours, could cause a significant increase in the level of lactic dehydrogenase
(LDH) in the plasma of infected mice. Cytolysis, such as is apparently caused
by the NKLA, could well increase LDH levels and it seemed possible that the
Riley agent and the NKLA were one and the same entity. This viewpoint was
strengthened when it was shown (Rowson, personal communication) that the
NKLA did elevate LDH levels in infected mice. However, neither the S37
tumour, which is known to contain the Riley agent, nor serum from S37 bearing
mice induced any marked anaemia in CBA mice. Thus what had seemed a
tempting hypothesis has been shelved pending further investigation.
Taylor and McDowell (1949) and Law and Dunn (1951) have reported the
presence of virus-like agents as contaminants of transplanted mouse leukaemias.
It may be that these agents are similar to the NKLA particularly as that of Law
and Dunn appeared to destroy lymphocytes.
The other principal group ofviruses associated with tumours are the leukaemia
viruses such as those recently described by Dalton et al. (1961). These agents
do not appear to cause anaemia and their relevance to the present study is
not immediately apparent. Serum was however taken from mice of the high
leukaemic AK strain both before and after the development of leukaemia.
This serum did not, however, cause anaemiawhen injected into CBA mice, neither
was anaemia apparent in leukaemic AK mice.
Confining the argument to the NKLA, it is not at present possible to say how
the agent came to be associated with the tumour.
It remains to be seen how widespread are haemolytic agents associated with
transplanted tumours. The relationship between the tumour and the virus
needs tb be elucidated as does the mechanism by which blood cells are destroyed
by virus. Work in progress concerns these points.
SUMMARY
Anaemia associated with the NK/Ly ascites tumour in mice has been investi-
gated. Evidence is presented suggesting that the anaemia is caused by a replica-
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ting agent which can be obtained free from the tumour cells. Experiments with
the agent are described which strongly suggest it is viroid in nature.
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